Delivery Order SPE2DB24D2205-SPE2DB26FDSJR
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order on September 25, 2025, by the Defense Logistics Agency's Medical Supply Chain to supply Biktarvy 50-200-25 mg tablets in quantities of 30 units. The contract is valued at $79,539.38 and operates under a firm fixed-price structure with an ultimate completion date of September 26, 2025. This non-competitive, non-set-aside delivery order will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $20,817.64 by the Defense Logistics Agency (DLA) on August 14, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. The contract is firm fixed price, competitively awarded with no set-aside designation, and has an ultimate completion date of August 15, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 7, 2025, by the Defense Logistics Agency for $50,225.55 to supply Biktarvy 50-200-25 mg tablets in quantities of 30. This firm fixed-price delivery order, which is not set-aside designated, is expected to be completed by August 8, 2025, and will be performed at the contractor's Conshohocken facility. The award represents a continuation of...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a competitively awarded delivery order from the Defense Logistics Agency (DLA) valued at $1,548.16 for Biktarvy 50-200-25 mg tablets in quantities of 30 units. This contract is classified as a firm fixed price delivery order with an ultimate completion date of July 25, 2025, and no set-aside designation. The award serves the federal medical supply chain supporting military and veteran healthcare systems through...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 11, 2025, for the supply of Biktarvy 50-200-25 mg tablets (30-count unit dose packages) valued at $28,563.74. This competitively awarded, firm fixed-price delivery order is funded by the Defense Logistics Agency (DLA), a defense agency responsible for supplying pharmaceuticals and medical materiel to military health systems. The contract is...
- The Defense Logistics Agency awarded a $28,767.57 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. The contract was competitively awarded without set-aside designation and is scheduled for completion by September 24, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is the awardee and will perform the work at its corporate office location. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a delivery order valued at $65,345.95 to AmerisourceBergen Drug Corp for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. The contract, awarded on August 28, 2025, with an ultimate completion date of August 29, 2025, utilizes firm fixed pricing and carries no set-aside designation, indicating it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $26,117.08 to AmerisourceBergen Drug Corp for Biktarvy 50-200-25 mg tablets (30-count units) on July 22, 2025, with an ultimate completion date of July 23, 2025. This firm fixed-price, non-set-aside contract was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $53,908.10 to AmerisourceBergen Drug Corp for Biktarvy 50-200-25 mg tablets (30-count units) on August 6, 2025, with an ultimate completion date of August 7, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract for pharmaceutical supply to support federal medical procurement needs. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order valued at approximately $75,900 to AmerisourceBergen Drug Corp for the supply of Biktarvy 50-200-25 mg tablets (30-count units). The contract is a firm fixed-price delivery order with no set-aside designation, issued on June 20, 2025, with an ultimate completion date of June 23, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and serves as a critical vendor for federal...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB26FDSJRDelivery Order
AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency (DLA) for $87,877.92 to supply Biktarvy 50-200-25 mg tablets (30-count units), with an ultimate completion date of October 16, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The DLA Troop Support Medical program plays a critical role in providing pharmaceutical commodities and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems, with AmerisourceBergen positioned as a key vendor within the broader pharmaceutical supply chain supporting military and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $87.9k | 10/15/25 |